Ximbio, which is part of the technology transfer team within
Thus, Ximbio reduces requirement of time and resources as well as eases the administrative burden for researchers when distributing research tools. In the partnership Ximbio is responsible for the production, marketing and distribution of the reagents. Financial returns from commercialized reagents are shared with University of Helsinki and inventors. Ximbio’s share is fed directly back to CRUK to continue investment in cancer research.
Reagents are always linked to the originating inventor and institution at Ximbio’s website
UH collaboration with Ximbio is managed via Helsinki Innovation Services (HIS), which is a fully owned subsidiary of UH. UH distributes inventors’ share of income according to the
Why use Ximbio?
- Make your reagents available to the global life science community
- Ximbio stores and protects your reagents
- Ximbio manufactures and reproduces your reagents and delivers finished products to the end user or licensee
- Ximbio’s extensive infrastructure saves time and provides added resources to HIS
- Ximbio is a non-profit, so our missions are aligned
How to use Ximbio?
- Submit your reagent with an
for . HIS colleagues together with Ximbio takes care of the rest. HIS and Ximbio will clarify the ownership of the reagents and dependency on third party rights.
This is a great opportunity to participate in the
For more information and assistance, please be in contact with HIS:
- Gen Tamjar,
, tel. 050 377 3384 - Eveliina Jutila,
, tel. 050 476 3457 - Andrea Dichlberger,
, tel. 045 179 0200